相关实验视频
Updated: Jul 21, 2025

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
1.1K
管理与JAK抑制剂相关的心血管和癌症风险
Victor Yang1, Tue W Kragstrup2,3,4, Christopher McMaster1,5,6
1Department of Rheumatology, Level 1, North Wing, Heidelberg Repatriation Hospital, Austin Health, 300 Waterdale Road, PO Box 5444, Heidelberg West, VIC, 3081, Australia.
Drug safety
|July 25, 2023
概括
简氏激酶抑制剂 (JAKi) 对炎症性疾病有前途,但携带心血管和癌症风险,正如风湿性关节炎试验所显示的那样. 谨慎的患者选择对于安全使用JAKi至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 类风湿病学 类风湿病学
背景情况:
- 简氏激酶抑制剂 (JAKi) 是慢性炎症疾病的有效免疫调节疗法.
- 人们对与JAKi相关的心血管和癌症风险表示担忧,特别是在ORAL监测试验中.
研究的目的:
- 审查与JAKi相关的心血管和癌症风险的监管响应,数据,生物可信性和临床影响.
- 为指导临床医生在考虑JAKi治疗的患者导航这些风险.
主要方法:
- 对ORAL监控试验数据和随后的观察性研究的审查.
- 对监管反应的分析和更新的临床指南.
- 讨论JAKi使用的生物可信性和风险-收益考虑.
主要成果:
- 在ORAL监测试验中,托法西替尼在风湿性关节炎患者中增加了主要心血管不良事件和癌症的风险,这些患者具有心血管风险因素.
- 随后的观察数据证实了这些发现,尽管在所有患者群体中可能没有明显的风险.
- 监管机构更新了关于JAKi使用的建议.
结论:
- 虽然JAKi提供了显著的治疗益处,但它们的使用需要仔细考虑相关的心血管和癌症风险.
- 考虑风险因素和替代治疗方法的个性化患者评估对于优化JAKi治疗至关重要.
- 进一步的研究和持续的监测是必要的,以充分理解和管理JAKi相关的风险在不同的患者群体.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
206
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
206
Cardiomyopathy VI: Nursing Management
13
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
13
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K

